We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




First-Of-Its-Kind AI-Enabled Smart Microscopy Platform to Improve Precision in Cancer Diagnostics

By LabMedica International staff writers
Posted on 04 Aug 2023

Presently, drug developers and healthcare practitioners depend on antiquated methodologies to tackle increasingly complex tasks such as diagnosing diseases, quantifying biomarkers, and predicting responses to innovative treatments. Various companies have attempted to modernize the approach by digitizing specimens and adding more markers to a single slide, yet they still face the challenges of less than 1% of tissue specimens being analyzed and the inability to visualize complex structures and intercellular distributions in three dimensions. Now, a groundbreaking 3D spatial biology platform can rapidly digitize entire tissue specimens without causing any damage. The platform also provides AI-powered quantitative analysis to respond to crucial queries from clinicians and drug developers with greater precision and certainty.

Alpenglow Biosciences (Seattle, WA, USA) is using its proprietary multi-resolution 3Di platform for 3D spatial biology to develop artificial intelligence (AI) enabled smart microscopy. Alpenglow, in collaboration with CorePlus (Ponce, Puerto Rico), will utilize AI and 3D spatial biology to advance pathology from 2D qualitative to 3D quantitative. 3D imaging generates significantly more data than traditional slide-based methods by digitizing entire biopsy specimens instead of a single slice. AI and machine learning algorithms play a vital role in quantifying key biomarkers and identifying areas that require a more in-depth pathologist review. The aim is to automate the selection of tissue regions that require further scrutiny, which could eventually be instrumental in diagnosis or predicting responses to new therapies.

Alpenglow is advancing its smart microscopy platform, which employs its multi-resolution open-top light sheet microscope. Currently, the process for selecting areas of interest is manual and must be performed after data processing. Alpenglow plans to devise solutions for the quick processing of vast microscopy datasets, which can be a terabyte or larger in size, and locate areas of interest across extensive volumes using AI for higher sub-micron resolution imaging and additional quantitative analysis. As part of the collaboration, CorePlus will annotate 3D prostate biopsy images to train AI models to recognize critical tissue structures, including cancer cells, immune cells, and vessels.

In order to develop the next-generation AI-powered imaging technology, Alpenglow is integrating NVIDIA Holoscan, a leading platform for constructing medical devices that facilitate AI edge computing on 3Di. Additionally, Alpenglow will utilize NVIDIA IGX, a robust edge AI hardware platform, to function alongside 3Di. As a participant in the NVIDIA Inception program for innovative startups, Alpenglow is closely collaborating with the NVIDIA healthcare team to harness its GPU-accelerated image processing pipeline and expedite image processing on terabyte-scale datasets to enable automated region of interest detection. Alpenglow aims to speed up traditional pathology workflows, which can take from days to weeks, and deliver results in merely hours using the whole tissue sample.

“The future of pathology is 3D,” said Dr. Nicholas Reder, MD, MPH and CEO of Alpenglow Biosciences. “Alpenglow is poised to break the antiquated glass slide paradigm of pathology and usher in 3D spatial biology.”

Related Links:
Alpenglow Biosciences
CorePlus

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.